-
Kan, WL, Dhagat, U, Hercus, TR, Kaufmann, KB, Nero, TL, Zeng, AGX, Toubia, J, Barry, EF, Broughton, SE, Gomez, GA, et al.
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia.
2020
view publication
-
Brown, LM, Bartolo, RC, Davidson, NM, Schmidt, B, Brooks, I, Challis, J, Petrovic, V, Khuong‐Quang, D, Mechinaud, F, Khaw, SL, et al.
Targeted therapy and disease monitoring in CNTRL‐FGFR1‐driven leukaemia.
Pediatric Blood & Cancer
66(10)
:
e27897
2019
view publication
-
Meyer, C, Lopes, BA, Caye-Eude, A, Cavé, H, Arfeuille, C, Cuccuini, W, Sutton, R, Venn, NC, Oh, SH, Tsaur, G, et al.
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions.
Leukemia
33(9)
:
2306 -2340
2019
view publication
-
Salmon, J, Pomilio, G, Moujalled, D, Litalien, V, MacRaild, S, Teh, C, Rijal, S, Ivey, A, Teh, TC, Ekert, P, et al.
ENHANCING EXPRESSION OF PRO-APOPTOTIC FACTORS THROUGH INHIBITION OF HDACS DRIVES P53-INDEPENDENT SYNERGY WITH VENETOCLAX FOR THE TREATMENT OF AML.
Experimental Hematology
76:
s54
2019
view publication
-
Moujalled, D, Hanna, D, Pomillio, G, Litalien, V, Fleming, S, Chanrion, M, Maragno, A-L, Kraus-Berthier, L, Khaw, S, Lessene, G, et al.
IDENTIFICATION OF POTENT BH3-MIMETIC COMBINATIONS TARGETING PRO-SURVIVAL PATHWAYS IN HUMAN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Experimental Hematology
76:
s79 -s80
2019
view publication